Search Ontology:
ChEBI

(S)-nicotine

Term ID
CHEBI:17688
Synonyms
  • (-)-3-(1-Methyl-2-pyrrolidyl)pyridine
  • (-)-3-(N-Methylpyrrolidino)pyridine
  • (-)-nicotine
  • (R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
  • (S)-(-)-nicotine
  • (S)-3-(1-methylpyrrolidin-2-yl)pyridine
  • (S)-3-(N-methylpyrrolidin-2-yl)pyridine
  • (S)-nicotine
  • 1-Methyl-2-(3-pyridyl)pyrrolidine
  • 3-(1-Methyl-2-pyrollidinyl)pyridine
  • 3-(1-Methylpyrrolidin-2-yl)pyridine
  • 3-(2-(N-methylpyrrolidinyl))pyridine
  • 3-(N-methylpyrollidino)pyridine
  • 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
  • L(-)-nicotine
  • L-3-(1-Methyl-2-pyrrolidyl)pyridine
  • L-Nicotine
  • Nicotine
Definition
A 3-(1-methylpyrrolidin-2-yl)pyridine in which the chiral centre has S-configuration. The naturally occurring and most active enantiomer of nicotine, isolated from Nicotiana tabacum.
References
  • beilstein:3604351
  • bpdb:485
  • cas:54-11-5
  • drugbank:DB00184
  • drugcentral:1920
  • hmdb:HMDB0001934
  • kegg.compound:C00745
  • kegg.drug:D03365
  • knapsack:C00002057
  • lincs.smallmolecule:LSM-2093
  • metacyc.compound:NICOTINE
  • pdb-ccd:NCT
  • pubmed:11209966
  • pubmed:11322615
  • pubmed:11406005
  • pubmed:11719700
  • pubmed:11768184
  • pubmed:11821649
  • pubmed:11851194
  • pubmed:12575980
  • pubmed:12692774
  • pubmed:12769614
  • pubmed:12850578
  • pubmed:12971663
  • pubmed:13590907
  • pubmed:14674846
  • pubmed:14761239
  • pubmed:14975706
  • pubmed:15019421
  • pubmed:15027713
  • pubmed:15251917
  • pubmed:15276225
  • pubmed:15380834
  • pubmed:15502843
  • pubmed:15527885
  • pubmed:15707677
  • pubmed:15734728
  • pubmed:15826609
  • pubmed:15894687
  • pubmed:15902919
  • pubmed:15960296
  • pubmed:15963341
  • pubmed:16059663
  • pubmed:16212709
  • pubmed:16333621
  • pubmed:16370520
  • pubmed:16496293
  • pubmed:17023324
  • pubmed:17206646
  • pubmed:17292347
  • pubmed:17350101
  • pubmed:17498763
  • pubmed:17504235
  • pubmed:17525204
  • pubmed:17560039
  • pubmed:17683794
  • pubmed:18380035
  • pubmed:18383130
  • pubmed:18490768
  • pubmed:18683238
  • pubmed:18685152
  • pubmed:18805442
  • pubmed:18922921
  • pubmed:19100291
  • pubmed:19100331
  • pubmed:19287496
  • pubmed:19389046
  • pubmed:19448649
  • pubmed:19465085
  • pubmed:19850423
  • pubmed:19954906
  • pubmed:21521420
  • pubmed:21636612
  • pubmed:21822688
  • pubmed:21945235
  • pubmed:21947355
  • pubmed:22030716
  • pubmed:22129149
  • pubmed:22218403
  • pubmed:22265518
  • pubmed:22331007
  • pubmed:22377934
  • pubmed:22459798
  • pubmed:22529223
  • pubmed:22530136
  • pubmed:27951416
  • pubmed:28187919
  • pubmed:28391535
  • pubmed:28574230
  • pubmed:28641297
  • pubmed:28678400
  • pubmed:28683421
  • pubmed:28686840
  • pubmed:28698187
  • pubmed:28700952
  • pubmed:28704277
  • pubmed:28710519
  • pubmed:28711472
  • pubmed:28714396
  • pubmed:28718768
  • pubmed:28718828
  • pubmed:28726253
  • pubmed:28735272
  • reaxys:82109
  • wikipedia.en:Nicotine
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from (S)-nicotine
Phenotype where environments contain (S)-nicotine
Phenotype modified by environments containing (S)-nicotine
Phenotype affecting (S)-nicotine
Human Disease Model